Combining Population-Based Studies and Cross-Tissue Single-Cell RNA Sequencing Reveal Hepatocyte Growth Factor is a Potential Drug Target in Myasthenia Gravis
Rui Fan(Chongqing Medical University), Fei Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Dan Lu(Harbin University of Science and Technology), Wenjun Que(The Affiliated Yongchuan Hospital of Chongqing Medical University), Sisi Jing(Chongqing Medical University), Jing Dong(Fourth Hospital of Hebei Medical University), Yaoqi Gan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhihan Zhang(Beijing Tongren Hospital), Linqi Liu(University of Science and Technology of China)
Cited by 0
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis
|Contraception|2008|206
Stability study and optimization design of small-spacing two-well (SSTW) salt caverns for natural gas storages
|Journal of Energy Storage|2019|161
SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
|Cellular Physiology and Biochemistry|2015|124